{"PubmedArticle": [{"MedlineCitation": {"SpaceFlightMission": [], "OtherID": [], "InvestigatorList": [], "OtherAbstract": [], "CitationSubset": ["IM"], "KeywordList": [], "GeneralNote": [], "PMID": "17925494", "DateCompleted": {"Year": "2007", "Month": "11", "Day": "08"}, "DateRevised": {"Year": "2018", "Month": "12", "Day": "11"}, "Article": {"ArticleDate": [{"Year": "2007", "Month": "10", "Day": "09"}], "Language": ["eng"], "ELocationID": [], "Journal": {"ISSN": "1542-6270", "JournalIssue": {"Volume": "41", "Issue": "11", "PubDate": {"Year": "2007", "Month": "Nov"}}, "Title": "The Annals of pharmacotherapy", "ISOAbbreviation": "Ann Pharmacother"}, "ArticleTitle": "Lack of pharmacokinetic interaction between St. John's wort and prednisone.", "Pagination": {"StartPage": "1819", "EndPage": "1824", "MedlinePgn": "1819-24"}, "Abstract": {"AbstractText": ["St. John's wort (SJW) is a popular dietary supplement involved in numerous dietary supplement-drug interactions with prescription and non-prescription drugs. The supplement has been shown to affect the metabolism of various CYP3A4 substrates. The CYP3A4 pathway mediates the metabolism of a large number of drug entities, including the corticosteroids prednisone and prednisolone.", "To examine the effects of long-term SJW administration on the pharmacokinetics of prednisone and its reversible metabolite prednisolone in male subjects.", "Eight male subjects participated in this single-dose study. The pharmacokinetics of prednisone and prednisolone were evaluated before and after 28 days of SJW administration. Plasma corticosteroid concentrations were determined using a normal phase high-performance liquid chromatography assay. Model-independent methods were used to evaluate corticosteroid pharmacokinetics.", "Twenty-eight days of SJW treatment resulted in no significant alterations in the pharmacokinetic parameters for prednisone or prednisolone. Oral administration of prednisone resulted in prednisone mean +/- SD area under the curves (AUCs) of 115.89 +/- 39.52 microg x h/L prior to SJW treatment and 128.76 +/- 32.71 microg x h/L after 28 days of treatment. Prednisolone mean AUCs were 714.19 +/- 153.29 microg x h/L before SJW administration and 700.74 +/- 89.68 microg x h/L after treatment.", "Concurrent administration of SJW had no significant effect on the single-dose pharmacokinetics of prednisone or metabolic prednisolone in male subjects."]}, "AuthorList": [{"AffiliationInfo": [{"Identifier": [], "Affiliation": "College of Pharmacy & Health Sciences, Texas Southern University, Houston, TX 77004, USA. bellec@tsu.edu"}], "Identifier": [], "LastName": "Bell", "ForeName": "Edward C", "Initials": "EC"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Ravis", "ForeName": "William R", "Initials": "WR"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Chan", "ForeName": "Hui Min", "Initials": "HM"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Lin", "ForeName": "Yuh-Jing", "Initials": "YJ"}], "PublicationTypeList": ["Clinical Trial", "Journal Article"]}, "MedlineJournalInfo": {"Country": "United States", "MedlineTA": "Ann Pharmacother", "NlmUniqueID": "9203131", "ISSNLinking": "1060-0280"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Glucocorticoids"}, {"RegistryNumber": "0", "NameOfSubstance": "Plant Preparations"}, {"RegistryNumber": "9035-51-2", "NameOfSubstance": "Cytochrome P-450 Enzyme System"}, {"RegistryNumber": "9PHQ9Y1OLM", "NameOfSubstance": "Prednisolone"}, {"RegistryNumber": "EC 1.14.14.1", "NameOfSubstance": "Cytochrome P-450 CYP3A"}, {"RegistryNumber": "EC 1.14.14.55", "NameOfSubstance": "CYP3A4 protein, human"}, {"RegistryNumber": "VB0R961HZT", "NameOfSubstance": "Prednisone"}], "MeshHeadingList": [{"QualifierName": [], "DescriptorName": "Adult"}, {"QualifierName": [], "DescriptorName": "Chromatography, High Pressure Liquid"}, {"QualifierName": [], "DescriptorName": "Cytochrome P-450 CYP3A"}, {"QualifierName": ["metabolism"], "DescriptorName": "Cytochrome P-450 Enzyme System"}, {"QualifierName": [], "DescriptorName": "Dietary Supplements"}, {"QualifierName": [], "DescriptorName": "Drug Administration Schedule"}, {"QualifierName": ["blood", "pharmacokinetics"], "DescriptorName": "Glucocorticoids"}, {"QualifierName": [], "DescriptorName": "Herb-Drug Interactions"}, {"QualifierName": [], "DescriptorName": "Humans"}, {"QualifierName": ["chemistry"], "DescriptorName": "Hypericum"}, {"QualifierName": [], "DescriptorName": "Male"}, {"QualifierName": ["pharmacology"], "DescriptorName": "Plant Preparations"}, {"QualifierName": [], "DescriptorName": "Plants, Medicinal"}, {"QualifierName": ["blood", "pharmacokinetics"], "DescriptorName": "Prednisolone"}, {"QualifierName": ["blood", "metabolism", "pharmacokinetics"], "DescriptorName": "Prednisone"}]}, "PubmedData": {"ReferenceList": [], "History": [{"Year": "2007", "Month": "10", "Day": "11", "Hour": "9", "Minute": "0"}, {"Year": "2007", "Month": "11", "Day": "9", "Hour": "9", "Minute": "0"}, {"Year": "2007", "Month": "10", "Day": "11", "Hour": "9", "Minute": "0"}], "PublicationStatus": "ppublish", "ArticleIdList": ["17925494", "10.1345/aph.1K316", "aph.1K316"]}}], "PubmedBookArticle": []}